Status and phase
Conditions
Treatments
About
This study is a randomized, parallel, open-label, multicenter, phase IV clinical trial to assess the efficacy and safety of pregabalin and alpha-lipoic acid combination compared with each monotherapy in patients with diabetic peripheral neuropathy for 12 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
151 participants in 3 patient groups
Loading...
Central trial contact
JC Won
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal